Repurposing a neurodegenerative disease drug to treat Gram-negative antibiotic-resistant bacterial sepsis

Overview of attention for article published in Science Translational Medicine, November 2020

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (89th percentile)

Mentioned by

news: 32 news outlets
blogs: 1 blog

twitter: 36 X users
facebook: 1 Facebook page

Readers on

mendeley: 79 Mendeley

So far, Altmetric has seen 41 X posts from 36 X users, with an upper bound of 169,167 followers.

RT @CentreImpactAMR: Collaboration at its finest! One of our Centre leaders Jian Li and his team involved in a study on how repurposing a n…

Collaboration at its finest! One of our Centre leaders Jian Li and his team involved in a study on how repurposing a neurodegenerative disease drug can treat Gram-negative antibiotic-resistant bacterial sepsis https://t.co/8olsz7mJzp

RT @recherche_anima: 🤞🙏 #Septicemia: a drug candidate against neurodegeneration, is able to reverse the resistance to polymyxin, a last res…

🤞🙏 #Septicemia: a drug candidate against neurodegeneration, is able to reverse the resistance to polymyxin, a last resort #antibiotic, to fight E. coli, P. aeruginosa and K. pneumoniae in #mice 🐭. To be continued 🤩 https://t.co/fSi9Q7zsny https://t.co…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 37 additional X posts.